Romifidine: Difference between revisions
Content deleted Content added
populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot |
auto mw |
||
(20 intermediate revisions by 15 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = 448113917 |
||
| IUPAC_name = N-(2-bromo-6-fluorophenyl)-4,5-dihydro- |
| IUPAC_name = ''N''-(2-bromo-6-fluorophenyl)-4,5-dihydro-1''H''-imidazol-2-amine |
||
| image = Romifidine. |
| image = Romifidine.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
Line 15: | Line 16: | ||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
||
| legal_status = Veterinary |
| legal_status = Veterinary use only |
||
| routes_of_administration = IV |
| routes_of_administration = IV |
||
Line 23: | Line 24: | ||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 65896-16-4 |
| CAS_number = 65896-16-4 |
||
| ATCvet = yes |
| ATCvet = yes |
||
Line 33: | Line 35: | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = |
||
| UNII_Ref = {{fdacite| |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = 876351L05K |
| UNII = 876351L05K |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 64975 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=9 | H=9 | Br=1 | F=1 | N=3 |
| C=9 | H=9 | Br=1 | F=1 | N=3 |
||
| molecular_weight = 258.09 |
|||
| smiles = C1CN=C(N1)NC2=C(C=CC=C2Br)F |
| smiles = C1CN=C(N1)NC2=C(C=CC=C2Br)F |
||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C9H9BrFN3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14) |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = KDPNLRQZHDJRFU-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Romifidine''' is a [[medication|drug]] that is used in [[veterinary medicine]] as a sedative mainly in large animals such as horses,<ref>Spadavecchia C, Arendt-Nielsen L, Andersen OK, Spadavecchia L, Schatzmann U |
'''Romifidine''' is a [[medication|drug]] that is used in [[veterinary medicine]] as a sedative mainly in large animals such as horses,<ref>{{cite journal | vauthors = Spadavecchia C, Arendt-Nielsen L, Andersen OK, Spadavecchia L, Schatzmann U | title = Effect of romifidine on the nociceptive withdrawal reflex and temporal summation in conscious horses | journal = American Journal of Veterinary Research | volume = 66 | issue = 11 | pages = 1992–8 | date = November 2005 | pmid = 16334961 | doi = 10.2460/ajvr.2005.66.1992 | doi-access = free }}</ref> although it may be used in a wide variety of species.<ref>{{cite journal | vauthors = De Lucas JJ, Rodríguez C, Marín M, González F, Ballesteros C, San Andrés MI | title = Pharmacokinetics of intramuscular ketamine in young ostriches premedicated with romifidine | journal = Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine | volume = 54 | issue = 1 | pages = 48–50 | date = February 2007 | pmid = 17359455 | doi = 10.1111/j.1439-0442.2007.00910.x | doi-access = free }}</ref><ref>{{cite journal | vauthors = Belda E, Laredo FG, Escobar M, Soler M, Lucas X, Agut A | title = Sedative and cardiorespiratory effects of three doses of romifidine in comparison with medetomidine in five cats | journal = The Veterinary Record | volume = 162 | issue = 3 | pages = 82–7 | date = January 2008 | pmid = 18204032 | doi = 10.1136/vr.162.3.82 | s2cid = 41300654 }}</ref> It is not used in humans, but is closely related in structure to the commonly used drug [[clonidine]]. |
||
Romifidine acts as an [[agonist]] at the α<sub>2</sub> [[adrenergic receptor]] subtype. Side effects can include [[bradycardia]] and [[respiratory depression]]. It is often used alongside other sedative or analgesic drugs such as [[ketamine]] or [[butorphanol]].<ref>Corletto F, Raisis AA, Brearley JC |
Romifidine acts as an [[agonist]] at the α<sub>2</sub> [[adrenergic receptor]] subtype. Side effects can include [[bradycardia]] and [[respiratory depression]]. It is often used alongside other sedative or analgesic drugs such as [[ketamine]] or [[butorphanol]].<ref>{{cite journal | vauthors = Corletto F, Raisis AA, Brearley JC | title = Comparison of morphine and butorphanol as pre-anaesthetic agents in combination with romifidine for field castration in ponies | journal = Veterinary Anaesthesia and Analgesia | volume = 32 | issue = 1 | pages = 16–22 | date = January 2005 | pmid = 15663735 | doi = 10.1111/j.1467-2995.2004.00184.x }}</ref><ref>{{cite journal | vauthors = Kerr CL, McDonell WN, Young SS | title = Cardiopulmonary effects of romifidine/ketamine or xylazine/ketamine when used for short duration anesthesia in the horse | journal = Canadian Journal of Veterinary Research | volume = 68 | issue = 4 | pages = 274–82 | date = October 2004 | pmid = 15581222 | pmc = 1111358 }}</ref> [[Yohimbine]] can be used as an [[antidote]] to rapidly reverse the effects. |
||
⚫ | |||
⚫ | |||
{{reflist|2}} |
{{reflist|2}} |
||
⚫ | |||
{{Hypnotics and sedatives}} |
{{Hypnotics and sedatives}} |
||
⚫ | |||
[[Category:Analgesics]] |
[[Category:Analgesics]] |
||
[[Category: |
[[Category:Alpha-2 adrenergic receptor agonists]] |
||
[[Category:Alpha-adrenergic agonists]] |
|||
[[Category:Organobromides]] |
[[Category:Organobromides]] |
||
[[Category: |
[[Category:Fluoroarenes]] |
||
[[Category:Anilines]] |
[[Category:Anilines]] |
||
[[Category:Sedatives]] |
|||
[[Category:Imidazolines]] |
|||
{{ |
{{sedative-stub}} |
||
[[fr:Romifidine]] |